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Abstract
Background: Increased neuronal excitability and spontaneous firing are hallmark characteristics of injured sensory
neurons. Changes in expression of various voltage-gated Na
+ channels (VGSCs) have been observed under
neuropathic conditions and there is evidence for the involvement of protein kinase C (PKC) in sensory
hyperexcitability. Here we demonstrate the contribution of PKC to P2X-evoked VGSC activation in dorsal root
ganglion (DRG) neurons in neuropathic conditions.
Results: Using the spinal nerve ligation (SNL) model of neuropathic pain and whole-cell patch clamp recordings of
dissociated DRG neurons, we examined changes in excitability of sensory neurons after nerve injury and observed
that P2X3 purinoceptor-mediated currents induced by α,β-meATP triggered activation of TTX-sensitive VGSCs in
neuropathic nociceptors only. Treatment of neuropathic DRGs with the PKC blocker staurosporine or calphostin C
decreased the α,β-meATP-induced Na
+ channels activity and reversed neuronal hypersensitivity. In current clamp
mode, α,β-meATP was able to evoke action-potentials more frequently in neuropathic neurons than in controls.
Pretreatment with calphostin C significantly decreased the proportion of sensitized neurons that generated action
potentials in response to α,β-meATP. Recordings measuring VGSC activity in neuropathic neurons show significant
change in amplitude and voltage dependence of sodium currents. In situ hybridization data indicate a dramatic
increase in expression of embryonic Nav1.3 channels in neuropathic DRG neurons. In a CHO cell line stably
expressing the Nav1.3 subunit, PKC inhibition caused both a significant shift in voltage-dependence of the channel
in the depolarizing direction and a decrease in current amplitude.
Conclusion: Neuropathic injury causes primary sensory neurons to become hyperexcitable to ATP-evoked P2X
receptor-mediated depolarization, a phenotypic switch sensitive to PKC modulation and mediated by increased
activity of TTX-sensitive VGSCs. Upregulation in VGSC activity after injury is likely mediated by increased expression
of the Nav1.3 subunit, and the function of the Nav1.3 channel is regulated by PKC.
Background
Neuronal hypersensitivity is a hallmark feature of neuro-
pathic pain. The ATP-gated ionotropic P2X3 receptor
[1,2] has been demonstrated to play significant roles in
neuronal hyperexcitability and neuropathic pain in
damaged sensory neurons [3-6]. To date, however, there
is no clear understanding of how the P2X3 receptor
influences neuronal hypersensitivity under neuropathic
pain conditions. If the P2X3 receptor contributes
directly to neuronal hypersensitivity, one might expect
an upregulation of its function after nerve damage. Con-
sistent with this hypothesis, some studies have described
increased P2X3 expression following nerve injury [7,8].
However, others have reported evidence of decreased
P2X3 expression in neuropathic conditions [9] with low-
ered or unchanged level of P2X receptor function in
subsets of dorsal root ganglion (DRG) neurons [10].
Indeed, while ATP evokes strong responses from neuro-
pathic sensory neurons, it is not clear whether this is a
direct effect of increased P2X3 currents, or an indirect
effect reflecting increased intrinsic neuronal excitability.
Numerous reports have demonstrated an association
between neuropathic injuries and changes in the expres-
sion of voltage-gated sodium channels (VGSC) [11]. One
of the most dramatic VGSC alterations after neuropathic
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any medium, provided the original work is properly cited.injury is the upregulation of the embryonic Nav1.3 a sub-
unit [12]. The Nav1.3 a subunit is highly expressed in
embryonic DRG neurons, but is developmentally regu-
lated such that it is only weakly expressed in adult DRG
neurons [13]. Regulation of gene expression is not the
only mechanism known to modulate VGSC function in
neurons. Changes in phosphorylation states mediated by
serine/threonine protein kinases have been shown to
directly affect functional properties of Nav1.2 [14], Nav1.7
and Nav1.8 [15,16]. Involvement of serine/threonine pro-
tein kinases, especially protein kinase C (PKC), in neuro-
pathic pain has been clearly demonstrated [17,18].
H o w e v e r ,am o d u l a t o r yr o l eo fP K Co nt h eN a v1.3 sub-
unit has yet to be determined.
The aim of the present study is to understand how
P2X3 receptors and Nav1.3 VGSCs contribute to neuro-
nal hyperexcitability in neuropathic DRG neurons. Here
we report that upregulation of Nav1.3 increases intrinsic
neuronal excitability, whereas ATP-gated currents
through P2X3 receptors contribute sufficient depolariza-
tion to elicit spikes in damaged DRG neurons. We also
show that PKC modulates neuronal hyperexcitability by
regulating the function of Nav1.3. These data provide
new insights into how injured peripheral nociceptors
mediate abnormal ectopic firing that could sustain neu-
ropathic pain.
Materials and methods
Neuropathic model
This study was conducted under a protocol that has
been approved by an ethical committee. The animals
were kept and experiments were performed at AstraZe-
neca R&D Montréal which has accreditation from
CCAC (Canadian Council on Animal Care), AAALAC
(Association for the Assessment and Accreditation of
Laboratory Animal Care) and/or approved by AZ GVC
(AstraZeneca Global Veterinary Council) for study
conduct.
Spinal nerve ligations (SNL) at L5 and L6 levels were
carried out in Sprague-Dawley male rats weighing
125-150 g following a protocol previously described by
Kim and Chung [19]. In summary, after inducing deep
anaesthesia using isoflurane inhalation, a 2 cm dorsal
incision was made approximately from L3 and S2 ver-
tebral regions. Paraspinal muscles on the left side were
detached from the spinous processes in order to reveal
the L5 and L6 spinal nerves. Once the nerves were
cleared from connective tissue, a tight ligation was made
on each nerve using a 4-0 silk thread. The muscles were
then moved back to the appropriate regions along the
vertebrae then the incision was sutured and antibiotic
ointment was applied. During surgery the animals were
given a constant flow of isoflurane inhalation to main-
tain deep anaesthesia.
Neuronal and non-neuronal cell culture
DRGs from lumbar segments L4-L6 were extracted from
naïve male Sprague-Dawley rats weighing 340-400 g
(Charles River Canada) under deep anaesthesia induced
by isoflurane.
For the SNL conditions, L5 and L6 lumbar segment
DRGs on the ipsilateral side of the ligation were har-
vested at 35-40 days post-injury under deep anaesthesia
induced by isoflurane.
Extracted DRGs were placed in ice-cold oxygenated
DMEM (Gibco) for removal of connective tissue and
dura mater. The isolated DRGs were then placed into
DMEM containing 1 mg/mL of papain and 2 mg/mL
collagenase type II (Sigma-Aldrich) and incubated for
1 h at 37°C and 100% humidity. After enzymatic diges-
tion, the DRGs were transferred into DMEM containing
10% FBS and 1% L-glutamine, dissociated into single
neurons by means of trituration using fire-polished pip-
ettes. Dissociated neurons were then plated onto 35 mm
cell culture dishes (Sarstedt) coated with laminin (BD
Bioscience) and poly-D-lysine (Sigma-Aldrich), and cul-
tured for 48 h at 37°C and 100% humidity in F-12
media (Gibco) containing 10% FBS, 1% L-glutamine as
well as 100 U/mL penicillin and streptomycin.
CHO cells stably expressing human Nav1.3 a subunit
(cell line CNahIII-12, [20]) were cultured in IMDM sup-
plemented with 10% fetal bovine serum, 1% sodium
hypoxanthine and thymidine (HT) supplement, 1%
MEM non-essential amino acids, 100 U/mL Penicillin
and streptomycin, and 400 μg/mL G418 (Gibco).
Patch-clamp recordings in DRG neurons and CHO cells
Whole-cell patch-clamp recordings on DRG neurons
were conducted using micropipettes produced by pulling
borosilicate glass tubes using a P-97 puller (Sutter
Instrument, Novato, CA), and fire-polishing with a
MP-830 microforge (Narishig e ,T o k y o ,J a p a n )t oat i p
resistance of 0.8-1 MΩ when filled with pipette solution,
pH 7.2, containing (in mM): 140 CsCl, 10 NaCl, 1 EGTA
and 5 HEPES. During recordings the neurons were con-
stantly perfused with a solution at pH 7.4, comprised of
(in mM): 98 choline-Cl, 42 NaCl, 3 KCl, 2 CaCl2,
2 MgCl2, 10 HEPES, 10 glucose, 25 TEA and 3 4-AP.
Membrane currents were recorded using an Axopatch
200B amplifier, digitized with a Digidata 3200A interface
(Axon Instruments, Foster City, CA.), and acquired at a
frequency of 5 kHz using pClamp 9. Voltage dependence
of activation was determined from peak currents in
response to 50 ms test pulses ranging from -80 to +90 mV.
Whole-cell patch-clamp recordings were also carried
out in CHO cells stably expressing the Nav1.3 a subunit.
The same voltage protocol was conducted using micro-
pipettes with a tip resistance of 2-4 MΩ filled with a
solution at pH 7.2, containing (in mM): 105 Cs-Asp,
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recordings the cells were constantly perfused with an
external solution at pH 7.4 containing (in mM):
130 NaCl, 4 KCl, 1.5 CaCl2,1M g C l 2, 10 HEPES and
5 glucose. For CHO cell recordings, compensation for
leak current was carried out using the P/4 protocol
included in the pClamp 9 acquisition software. For all
recordings the membrane capacitance (Cm)a n ds e r i e s
resistance (Rs)w e r em e a s u r e dt h r o u g ht h ep e a ka m p l i -
tude and decay constant of transients induced by repeti-
tive depolarizing pulses of 10 mV.
Tissue collection and preparation
Adult male Sprague-Dawley rats (Charles River, Saint-
Constant, Quebec, Canada) were euthanized by decapi-
tation. Spinal cords with DRG attached were rapidly
dissected, snap-frozen at -40°C in isopentane for 20 s
and stored at -80°C. Frozen spinal cord tissue with
DRGs attached were transversely cryosectioned at
14 μm and thaw-mounted onto Superfrost Plus slides
(VWR, Montreal, Quebec, Canada). Slides were stored
at -80°C until processing for in situ hybridization.
NaV1.3 riboprobe design and synthesis
A 409-base pair fragment spanning nt. 6325-6733 in the
3’-untranslated region of the rat Nav1.3 gene (accession
number NM_013119) was amplified in PCR from rat
genomic DNA using 5’-TATCCGTGTCAACTGGAC-3’
as the forward primer and 5’-ACTTGTGGACTTAG-
CAAC-3’ as the reverse primer. PCR cycling (reaction
m i x :1n go fg e n o m i cD N A ,0 . 2μM of each dNTP,
1 mM of each primer, 5 U of Taq DNA polymerase in
1×Taq DNA polymerase buffer) was 3 min at 95°C,
followed by 25 cycles of 30 s at 95°C, 45 s at 50°C and
30 s at 72°C. The amplicon was isolated on an agarose
gel using the QIAquick gel extraction kit (Qiagen, Mis-
sissauga, Ontario, Canada) and was ligated into pGEM-
T-Easy vector (Promega, Nepean, Ontario, Canada).
Plasmid from a single clone was purified using HiSpeed
Plasmid Midi kit (Qiagen). The Nav1.3 plasmid was line-
arized using NcoI and SpeI restriction enzymes (Pro-
mega). Antisense riboprobes were transcribed in vitro
using SP6 RNA polymerase (Promega) and radiolabeled
with
35S-UTP and
35S-CTP (800 Ci/mmol; Amersham
Biosciences, Inc). Following transcription, the Nav1.3
DNA template was digested with DNAse I (Promega)
and subsequently purified using G-50 Sepharose micro-
spin columns (GE Healthcare). The quality of labeled
riboprobes was verified by polyacrylamide-urea gel elec-
trophoresis and scintillation counting.
In situ hybridization (ISH) and histological analysis
ISH was performed on rat tissue sections as previously
described (Ahmad et al 2007). Briefly, tissue sections
were fixed with 4% paraformaldehyde, rinsed 3 times in
2 × standard sodium citrate buffer (2 × SSC), equili-
brated in 0.1 M triethanolamine, and treated with 0.25%
acetic anhydride in 0.1 M triethanolamine. After a rinse
in 2 × SSC and dehydration through an ethanol series
(50-100%), hybridization was performed in a buffer con-
taining 75% formamide (Sigma), 600 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 1 mM EDTA, 1 × Denhardt’ss o l u -
tion (Sigma), 50 μg/ml denatured salmon sperm DNA
(Sigma), 10% dextran sulfate (Sigma), 20 mM dithio-
threitol, and [
35S]-labeled cRNA probe (20 × 106 cpm/
ml) at 55°C overnight in chambers humidified with 75%
formamide.
Following hybridization, slides were rinsed twice in 2 ×
SSC at room temperature, treated with 20 μg/ml RNase
IA in RNase buffer (25 mM NaCl, 5 mM Tris-HCl pH
7.5, 0.5 mM EDTA pH 8.0) for 45 minutes at 37°C, and
washed to a final stringency of 0.1 × SSC at 70°C. Sec-
tions were then dehydrated and exposed to Kodak Bio-
max MR-2 film. After exposed to film, the slides were
dipped in Kodak NTB2 emulsion and exposed for 8
weeks at 4°C prior to development and counterstaining
with hematoxylin and eosin.
Film autoradiograms were digitized with a high-
resolution Xillix Microimager digital camera via the
MCID image analysis system (Imaging Research,
St-Catharines, Ontario, Canada). Bright- and darkfield
photomicrographs of emulsion-dipped tissue sections
were captured using a Leica (DMRBE/DM 4000B)
microscope equipped with a Leica DFC490 digital
camera. Digital images were transferred to Adobe
Photoshop 7.0 for minimal image processing.
Statistical analysis
Data are presented as mean ± S.E.M. All statistical ana-
lyses for the difference in means were carried out using
unpaired as well as paired Student’s t test and one-way
ANOVA followed by Bonferroni’s multiple comparison
tests. Normalized data were analyzed using nonpara-
metric Mann-Whitney U test.
Results
Neuropathic vs Naïve Purinergic Response
The overall morphology of DRG neurons was indistin-
guishable between naïve and neuropathic conditions.
Three distinct populations of neurons (small, medium and
large diameter) were present in all cultures. For the pur-
pose of this study, recordings were conducted only on
small diameter DRG neurons nociceptors, based on cell
body diameter of <30 μm, with functional P2X3 receptors
as determined by rapidly activating and fast desensitizing
current kinetics in response to the selective agonist a,b-
meATP. In DRG neurons from both control and neuro-
pathic animals, application of 10 μM a,b-meATP resulted
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pathic DRGs, a,b-meATP elicited a large transient spike,
which was not observed in control DRGs. We hypothe-
sized that this large inward spike in neuropathic neurons
might be caused by activation of VGSCs. In other words,
in neuropathic conditions, a small initial depolarization
caused by the inward current through P2X receptors and
not completely compensated by the clamp might be suffi-
cient to trigger a regenerative inward sodium spike. To
test this hypothesis, we applied a saturating concentration
of TTX (1 μM) and found that it selectively inhibited the
inward spike, leaving the purinergic ionotropic response at
levels similar to naïve neurons (Figure 1C, D). These data
suggest that after neuropathic injury, small diameter DRG
neurons express large TTX-sensitive voltage-dependent
sodium currents. It should be noted that we cannot be
certain that the recorded purinergic currents are purely
mediated by homomeric P2X3 receptors since it has been
reported that neuropathic DRG neurons show increased
expression of P2X2/3 heteromeric receptors [10], thus we
will simply describe purinergic currents as P2X responses.
To examine more directly how P2X receptor activa-
tion influences the electroresponsiveness of neuropathic
DRG neurons, we conducted current-clamp recordings
under resting conditions with no current injection, then
stimulated the DRG neurons with an application of
100 nM, 1 μMo r1 0μM a,b-meATP. In naïve DRG
neurons, a,b-meATP elicited dose-dependent cellular
depolarizations. However, these responses were generally
not sufficient to trigger neuronal firing (Figure 2A).
None of the naïve neurons tested at 100 nM a,b-
meATP generated action potentials, and 1 μMo r1 0
μM a,b-meATP applications induced action potentials
in about 7% of naïve DRG neurons. In contrast, a
greater proportion of neuropathic DRG neurons fired
action potentials in response to P2X stimulation. For
example, 100 nM a,b-meATP induced neuronal firing
in about 29% of DRG neurons, 1 μM a,b-meATP
induced 77% of neurons to fire, and all neuropathic neu-
rons generated action potentials in response to 10 μM
a,b-meATP (Figure 2B; N = 8-15 for each concentration
in each group).
Hyperexcitability of Neuropathic DRGs is Sensitive to PKC
To test the sensitivity of a,b-meATP-mediated current
responses of both naïve and neuropathic DRG neurons
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kinase blocker staurosporine. In voltage clamp experi-
ments, we found that the fast spike recorded in response
to a,b-meATP in neuropathic neurons was inhibited by
500 nM staurosporine (Figure 3A). The current density
of the response to 10 μM a,b-meATP was decreased by
76% (neuropathic: 115.41 ± 14.59 pA/pF; + staurospor-
ine: 27.57 ± 7.42 pA/pF; N = 4-9; Figure 3A, B).
Responses to a,b-meATP in naïve DRG neurons were
not sensitive to staurosporine (Figure 3C, D), nor were
the responses sensitive to pre-incubation with PKC acti-
vator PMA (data not shown). The a,b-meATP-evoked
transient spike in neuropathic neurons was also signifi-
cantly inhibited by calphostin C, a more selective inhibi-
tor of PKC (Figure 3A, B; neuropathic: 115.14 ±
14.59 pA/pF; + calphostin C: 9.88 ± 2.07 pA/pF; N = 6-9).
To ascertain how PKC affected the electroresponsive-
ness of naïve versus neuropathic DRG neurons to P2X
receptor activation, we conducted current-clamp experi-
ments to measure the effects of inhibiting PKC with 100
nM calphostin C on action potentials induced by 1 and
10 μM a,b-meATP. The difference in electroresponsive-
ness between naïve and neuropathic neurons was less
robust when we stimulated them with 100 nM a,b-
meATP, thus it was not included in this set of experi-
ments. In neuropathic DRG neurons activated with 1
μM a,b-meATP, only 29% of the neurons fired action
potentials when pre-exposed to calphostin C, compared
to 77% in absence of the PKC blocker (Figure 4A, B).
When the neurons were activated with 10 μM a,b-
meATP, 86% of neuropathic DRG neurons pre-treated
with calphostin C generated action potentials, compared
to 100% of untreated neuropathic neurons (Figure 4A,
B; N = 7-13 for each concentration in each group).
Neuropathic Injury-Induced Changes in Function and
Expression of Voltage-Gated Sodium Channels
To investigate the role of VGSCs in the hyperexcitable
responses of neuropathic DRG neurons to a,b-meATP-
evoked depolarization, we examined voltage-activated
sodium currents in voltage-clamp experiments. We
observed dramatically larger sodium current amplitudes
in neuropathic VGSCs, compared to naïve controls, over
a range of test potentials (Figure 5A). At the peak of the
current-voltage relationship, the current density mea-
sured in neuropathic DRG neurons was 200% larger
than in naïve neurons (Figure 5B). We also observed a
significant leftward shift (-5 mV) in the voltage depen-
dence of activation in neuropathic neurons (Figure 5C).
Therefore both an increased current amplitude and a
negative shift in voltage dependence of activation of
VGSCs contribute to the hypersensitivity of neuropathic
DRG neurons to purinergic stimulation.
To investigate expression changes in VGSC, we
performed in situ hybridization (ISH) experiments to
examine alterations of mRNA levels in DRG tissue
following SNL injury. We probed the expression of
the Nav1.3 gene based on reports that this VGSC
subunit increases significantly after SNL injury (see
discussion) and axotomy [12]. Nav1.3 mRNA expres-
sion was qualitatively assessed in DRG sections from
naïve, sham-operated and SNL-injured adult rats. In
both naïve and sham-operated rats, very weak Nav1.3
mRNA expression was detected over a subset of
small-, medium- and large-diameter neurons as iden-
tified using light microscopy (data not shown). In
contrast, unilateral ligation of L5 and L6 spinal
nerves resulted in robust upregulation of Nav1.3
mRNA expression within the corresponding ipsilat-
eral DRGs (Figure 6A, B). The increased level of
Nav1.3 mRNA expression was detected as early as 2
days post-injury, and remained upregulated at all
time points examined in small-, medium- and large-
diameter neurons. No changes were detected in the
intact L4 DRG, or in contralateral L5 and L6 DRGs
from SNL injured rats.
PKC Modulation of Nav1.3 Currents
As we did not observe any modulatory role of PKC on
the function of endogenous P2X3 receptors in DRG
neurons (Figure 3C, D), it is unlikely that PKC is modu-
lating neuronal excitability by altering P2X3 function. A
more likely mechanism for the effects of PKC on the
excitability of neuropathic DRG neurons is a modulation
of the activity of Nav1.3 channels. Because native DRG
neurons express a wide range of VGSC subtypes, and
since no pharmacological tools are available to isolate
the Nav1.3 activity, we tested this hypothesis in voltage-
clamp experiments on a CHO cell line stably expressing
the Nav1.3 subunit [20]. These cells displayed robust
and reproducible voltage-gated sodium currents (Figure
7A). After treatment with the PKC blocker calphostin C,
the voltage-dependence of Nav1.3 activity was shifted by
10 mV in the depolarizing direction (Figure 7B). PKC
inhibition also significantly reduced the amplitude of
Nav1.3 currents (Figure 7C). The current density at peak
activation was reduced by 46% by calphostin C (control:
335.46 ± 79.41 pA/pF; + calphostin C: 179.70 ± 23.53
pA/pF; N = 6-8).
Discussion
The present study suggests that activation of P2X recep-
tors elicits excessive firing in neuropathic DRG neurons
indirectly, through activation of upregulated Nav1.3
sodium channels. We also show that VGSC-mediated
hyperexcitability is modulated by PKC.
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Potentials
Neuropathic injury models such as SNL induce a wide
a r r a yo fc h a n g e si nt h ep h y s i o l o g yo fD R Gn e u r o n s .
Although SNL neurons display excessive firing of action
potentials in response to P2X activation, we cannot con-
clude that the ability to trigger hypersensitive responses
is exclusive to P2X receptors. Indeed, we also observed
similar abnormal action potential firing in a small num-
ber of neuropathic cells stimulated with the TRPV1 ago-
nist capsaicin (data not shown). We did not observe any
significant changes in the current amplitude of P2X
receptors in neuropathic DRG neurons treated with a
saturating concentration of TTX. This is in accordance
to another study of P2X receptor activity in injured sen-
sory neurons, where it was reported that the amplitude
of a,b-meATP-evoked currents in neuropathic small
diameter DRG neurons did not significantly differ from
those recorded from naïve neurons [10]. These observa-
tions are consistent with the idea that neuropathic neu-
rons are generally hyper-responsive to depolarizing
stimuli because of their intrinsic, voltage-dependent
hyperexcitability. P2X3 receptors are fast-desensitizing
while other receptor-channels such as TRPV1 have
slower kinetics of activation and desensitization [21].
Thus, ligand-gated cation channels with different
kinetics may elicit specific patterns and/or durations of
ectopic action potential firing.
PKC Modulation of Neuronal Hyperexcitability
The involvement of PKC in neuropathic pain has been
well demonstrated [22], and certain isoforms of PKC are
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the mechanism by which PKC regulates neuronal excit-
ability remains elusive. The function of several sensory
receptor-channels has been shown to be modulated by
PKC, such as TRPV1 [24], P2X2/3 [25], and ASICs [26].
In agreement with reports demonstrating the role of pro-
tein kinases in neuropathic pain mechanisms [17,27,28],
we show that sensitization to ATP of neuropathic neu-
rons can be inhibited by the wide-spectrum protein
kinase blocker staurosporine, as well as calphostin C, a
more selective PKC inhibitor [29] shown to be effective
against PKC isoforms involved in neuropathic pain [30].
We did not observe any effect of staurosporine or the
PKC activator PMA on P2X3 responses to a,b-meATP in
either naïve DRG neurons or HEK293 cells expressing
homomeric P2X3 receptors (data not shown), which
strongly suggests that PKC is not contributing to hyperexcit-
ability through a direct modulation of P2X receptors in
neuropathic DRG neurons. Our voltage-clamp recordings
conducted in the presence of PKC inhibitors showed a
decrease in the fast spike component of the inward current,
corresponding to a reduction in voltage-gated sodium cur-
rent, while the remaining P2X component was relatively
unchanged. The modulation of sodium channel activity by
calphostin C was also observed in our current-clamp experi-
ments where we demonstrated that PKC inhibition attenu-
ates the generation of action potentials in neuropathic
neurons. In line with evidence demonstrating modulation of
VGSCs by PKC [14-16,31-33], our results point to a major
role for PKC-modulated VGSCs in the hypersensitivity of
neuropathic DRG neurons to purinergic stimulation.
Upregulation of Nav1.3 Sodium Channels Expression and
Activity
In order to verify that PKC is regulating hyperexcitabil-
ity through modulation of VGSC, we first needed to
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Figure 5 Increased current amplitude and hyperpolarizing shift in voltage dependence of sensory sodium channels after neuropathic
injury. (A) Representative current-voltage relationship traces of VGSC currents recorded from naïve and neuropathic DRG neurons. (B) Analysis of
peak current amplitudes of voltage-gated sodium currents recorded at Vmax in naïve and neuropathic conditions (N = 4-5 for both groups, **p <
0.005). (C) Sodium channel conductance was fitted with the Boltzman function (see Materials and Methods) from voltage-gated currents
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Page 8 of 12identify which VGSC a subunit is up-regulated in neu-
ropathic DRG neurons. From our characterization of the
changes to the VGSC profile following SNL, the increase
in current amplitude and the hyperpolarizing shift in
voltage-dependence observed in neuropathic neurons
are likely caused by increased expression of Nav1.3. This
is consistent with reports showing an increase in the
expression of embryonic Nav1.3 a subunit expression in
DRG neurons after axotomy [12] and SNL injury
[34,35]. We cannot exclude possible changes in the
function of other VGSC subunits, such as Nav1.7 and
Nav1.8, which may contribute to neuropathic hyperex-
citability; however, their expression levels have been
shown to decrease after neuropathic injury [36,37].
Under normal conditions, Nav1.8 is the main generator
of action potentials in small diameter DRG neurons.
With respect to activation, Nav1.8 has a V0.5 of -16 to
-21 mV, whereas for Nav1.3 the V0.5 is -23 mV [38].
T h ed i f f e r e n c ei nv o l t a g e - d e p e n d e n c eo ft h et w oN a v
subunits corresponds to the difference in voltage-
dependence that we observed between neuropathic and
naïve DRG neurons, suggesting that Nav1.3 is a major
contributor to the VGSC-mediated currents in neuro-
pathic neurons.
Increased expression of the Nav1.3 a subunit following
SNL injury was confirmed through our ISH data. The
increased expression level was confined to the injured L5
and L6 DRGs and remained unaltered on the contralat-
eral (uninjured) DRGs. Changes in expression of VGSC
subunit mRNA have been reported in both rodents and
humans [12,34,37]. An incre a s ei ne x p r e s s i o no fN a v1.3
has been observed in trigeminal neuralgia patients [37],
suggesting a role for Nav1 . 3m o d u l a t i o ni np a t h o l o g i c a l
pain. Neuronal VGSCs are heteromeric complexes con-
taining a subunits associated with b subunits. These aux-
iliary subunits have been shown to modulate the function
of various a subunits [39]. Of the three b subunits identi-
fied so far, the most relevant here is the b3 subunit
because of its co-localization with Nav1.3 in small dia-
meter DRG neurons. Furthermore, the expression of
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B
Figure 6 Increased expression of Nav1.3 mRNA in DRG neurons following SNL injury. (A) Autoradiographic in situ hybridization data
showing increased levels of Nav1.3 mRNA in rat DRG neurons from 2 to 42 days after neuropathic injury. Arrows indicate the lumbar DRG level
ipsilateral to the SNL injury. Note that the increase in Nav1.3 mRNA occurs in the ipsilateral (injured) L5 and L6 DRGs, but remains unchanged in
(uninjured) L4 DRG and sham DRGs. Sham DRGs represent the 14 day post-injury time point. (B) High magnification (40×) images of emulsion-
dipped sections showing increased Nav1.3 mRNA expression in cell bodies of small diameter DRG neurons (arrows) on the ipsilateral side of the
nerve injury. Scale bar, 50 μm.
Mo et al. Molecular Pain 2011, 7:14
http://www.molecularpain.com/content/7/1/14
Page 9 of 12both proteins increases after neuropathic injury within
the same population of neurons [12,40]. However, the
modulatory effects of the b3 subunit on the Nav1.3 subu-
nit are not clear. Some have reported a depolarizing shift
in the voltage-dependence of activation and inactivation
of Nav1.3 [41,42], others reported no change in voltage-
dependence of activation, but did observe a decrease in
the rate of recovery from inactivation [20]. Unlike other
a subunits, the current density of Nav1.3 does not seem
to be affected by the presence of b subunits [20,40]. In
any case, the potential modulation of Nav1.3 by the aux-
iliary b3 subunit does not fit with the changes in the
function of Nav1.3 after neuropathic injury that we are
reporting here. However, because all these studies were
based on the use of transfected cell lines, the exact role
of native b3 subunits in sensory neurons is still unknown
so they could possibly facilitate neuronal hyperexcitabil-
ity. While some observed that treatment with antisense
oligodeoxynucleotides targeting Nav1.3 reversed changes
in pain responses associated with nerve injury [43,44],
others reported that decreasing expression of Nav1.3 was
n o ts u f f i c i e n tt oa t t e n u a t en europathic pain behaviours
[45,46]. There is currently no consensus on the involve-
ment of Nav1.3 function in mediating neuropathic pain.
Therefore, until a selective blocker is available for clinical
evaluation, its contribution to pain pathology will remain
unclear.
PKC Regulates Nav1.3 Activity
After identifying Nav1.3 as the VGSC a subunit predo-
minantly responsible for the hyperexcitability following
neuropathic injury, we examined the PKC modulation of
its function isolated in a heterologous system. From cur-
rents recorded from CHO- Nav1.3 cells, it was clear that
PKC enhances the function of Nav1.3 by increasing its
activity at more hyperpolarizing potentials and by
increasing its current amplitude, a combination that
could dramatically boost the sensitivity of DRG nocicep-
tors to a range of depolarizing stimuli. Several VGSC
isoforms have been shown to be modulated by PKC
[15,16,32], but we report here for the first time the posi-
tive regulation of Nav1.3 function by PKC in native as
well as recombinant cell preparations. The molecular
mechanisms of this modulation require further
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Figure 7 Nav1.3 activity is positively regulated by PKC. (A) Membrane potential depolarization induced Nav1.3-mediated sodium currents in
Nav1.3-transfected CHO cells evoked using stimulus protocol described in methods section. (B) Current-voltage relationship of Nav1.3 activity in
the presence and absence of 100 nM calphostin C (N = 6-8). (C) Voltage-dependent current density mediated by Nav1.3 channels in CHO cells in
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Page 10 of 12investigation to know if Nav1.3 is directly phosphory-
lated by PKC such as the Nav1.8 subunit [47]. In any
case, the identification of phosphorylated domain(s) in
the Nav1.3 subunit or associated proteins could provide
valuable information for the design of novel neuropathic
pain therapeutics.
Conclusions
The present study shows that injury-induced hyper-
responsiveness of DRG neurons to P2X activation is
mediated by increased expression of Nav1.3 sodium
channel subunit, and not due to any significant change
in the function of P2X receptors. We also provide evi-
dence for the first time that Nav1.3-mediated hyperex-
citability can be modulated by PKC, which directly
regulates the activity of Nav1.3 channels. This study
emphasizes the importance of VGSCs in injury-induced
increases in excitability to algogenic mediators, and pro-
vides new insights into functional regulation of Nav1.3
in injured peripheral neurons.
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